Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,268,535 papers from all fields of science
Search
Sign In
Create Free Account
Ribonuclease Inhibitor
Known as:
Ribonuclease/Angiogenin Inhibitor 1
, PRI
, RAI
Expand
Ribonuclease inhibitor (461 aa, ~50 kDa) is encoded by the human RNH1 gene. This protein plays a role in the inhibition of ribonucleases.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Angiogenic Process
Cytoplasm
Genes, Regulator
Leucine-Rich Repeat
Expand
Narrower (1)
placental ribonuclease inhibitor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Recurrent Disease in Juvenile Differentiated Thyroid Carcinoma: Prognostic Factors, Treatments, and Outcomes
J. Mihailović
,
Katarina Nikoletič
,
D. Srbovan
Journal of Nuclear Medicine
2014
Corpus ID: 33787967
The overall prognosis in pediatric differentiated thyroid carcinoma (DTC) is excellent. Recurrent disease is frequent, however…
Expand
Highly Cited
2009
Highly Cited
2009
Total thyroidectomy: a safe and effective treatment for Graves' disease.
Jing Liu
,
Anna E Bargren
,
S. Schaefer
,
Herb Chen
,
R. Sippel
Journal of Surgical Research
2009
Corpus ID: 22422577
Highly Cited
2007
Highly Cited
2007
Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma.
Massimo Salvatori
,
M. Raffaelli
,
+7 authors
R. Bellantone
European Journal of Surgical Oncology
2007
Corpus ID: 31027012
Highly Cited
2006
Highly Cited
2006
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
R. Tuttle
,
R. Leboeuf
,
+4 authors
C. Chan
Journal of Nuclear Medicine
2006
Corpus ID: 21954337
UNLABELLED Although 131I-iodine (RAI) therapy is a mainstay in the treatment of metastatic thyroid cancer, there is controversy…
Expand
Highly Cited
2003
Highly Cited
2003
Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
R. Dorn
,
J. Kopp
,
H. Vogt
,
P. Heidenreich
,
R. Carroll
,
S. Gulec
Journal of Nuclear Medicine
2003
Corpus ID: 11893825
UNLABELLED This study is a retrospective analysis of 124 differentiated thyroid cancer patients who underwent dosimetric…
Expand
Highly Cited
2003
Highly Cited
2003
Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000.
S.-M Chow
,
S. Law
,
+4 authors
W.-H Lau
Clinics in oncology
2003
Corpus ID: 31490116
Highly Cited
2002
Highly Cited
2002
The Neuron-Specific Rai (ShcC) Adaptor Protein Inhibits Apoptosis by Coupling Ret to the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway
G. Pelicci
,
Flavia Troglio
,
+6 authors
P. Pelicci
Molecular and Cellular Biology
2002
Corpus ID: 18793404
ABSTRACT Rai is a recently identified member of the family of Shc-like proteins, which are cytoplasmic signal transducers…
Expand
Review
2002
Review
2002
Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine.
A. Kang
,
C. Grant
,
G. Thompson
,
J. V. van Heerden
Surgery
2002
Corpus ID: 20187115
BACKGROUND First described 9 decades ago by H. S. Plummer, thyroidectomy and radioiodine remain the 2 therapeutic modalities for…
Expand
Highly Cited
1991
Highly Cited
1991
Interaction of human placental ribonuclease with placental ribonuclease inhibitor.
Robert Shapiro
,
Bert L. Vallee
Biochemistry
1991
Corpus ID: 25378776
The interactions of human placental ribonuclease inhibitor (PRI) with bovine pancreatic ribonuclease (RNase) A and human…
Expand
Highly Cited
1980
Highly Cited
1980
Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity.
F. Pandolfi
,
D. Strong
,
R. Slease
,
M. Smith
,
J. Ortaldo
,
R. Herberman
Blood
1980
Corpus ID: 23425308
A patient with T-cell chronic lymphocytic leukemia (T-CLL) is reported whose cells demonstrate in vitro suppression of normal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE